Merdad Parsey - Net Worth and Insider Trading
Merdad Parsey Net Worth
The estimated net worth of Merdad Parsey is at least $7 Million dollars as of 2025-01-15. Merdad Parsey is the Chief Medical Officer of Gilead Sciences Inc and owns about 80,801 shares of Gilead Sciences Inc (GILD) stock worth over $7 Million. Details can be seen in Merdad Parsey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Merdad Parsey has not made any transactions after 2024-11-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Merdad Parsey
Merdad Parsey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Merdad Parsey owns 3 companies in total, including Gilead Sciences Inc (GILD) , Arcus Biosciences Inc (RCUS) , and Sagimet Biosciences Inc (SGMT) .
Click here to see the complete history of Merdad Parsey’s form 4 insider trades.
Insider Ownership Summary of Merdad Parsey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 2024-11-27 | Chief Medical Officer |
| RCUS | Arcus Biosciences Inc | 2020-07-13 | director |
| SGMT | Sagimet Biosciences Inc | 2023-07-13 | director |
Merdad Parsey Latest Holdings Summary
Merdad Parsey currently owns a total of 1 stock. Merdad Parsey owns 80,801 shares of Gilead Sciences Inc (GILD) as of November 27, 2024, with a value of $7 Million.
Latest Holdings of Merdad Parsey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GILD | Gilead Sciences Inc | 2024-11-27 | 80,801 | 91.00 | 7,352,891 |
Holding Weightings of Merdad Parsey
Merdad Parsey Form 4 Trading Tracker
According to the SEC Form 4 filings, Merdad Parsey has made a total of 12 transactions in Gilead Sciences Inc (GILD) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Gilead Sciences Inc is the sale of 164,211 shares on November 27, 2024, which brought Merdad Parsey around $15 Million.
Insider Trading History of Merdad Parsey
- 1
Merdad Parsey Trading Performance
Merdad Parsey Ownership Network
Ownership Network List of Merdad Parsey
Ownership Network Relation of Merdad Parsey
Merdad Parsey Owned Company Details
What does Gilead Sciences Inc do?
Who are the key executives at Gilead Sciences Inc?
Merdad Parsey is the Chief Medical Officer of Gilead Sciences Inc. Other key executives at Gilead Sciences Inc include EVP & Chief Financial Officer Andrew D Dickinson , Chief Commercial Officer Johanna Mercier , and SVP & Controllership Sandra Patterson .
Gilead Sciences Inc (GILD) Insider Trades Summary
Over the past 18 months, Merdad Parsey made 8 insider transaction in Gilead Sciences Inc (GILD) with a net sale of 228,778. Other recent insider transactions involving Gilead Sciences Inc (GILD) include a net sale of 272,145 shares made by Andrew D Dickinson , a net sale of 57,602 shares made by Johanna Mercier , and a net sale of 6,788 shares made by Jeffrey Bluestone .
In summary, during the past 3 months, insiders sold 458,734 shares of Gilead Sciences Inc (GILD) in total and bought 0 shares, with a net sale of 458,734 shares. During the past 18 months, 565,313 shares of Gilead Sciences Inc (GILD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 565,313 shares.
Gilead Sciences Inc (GILD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gilead Sciences Inc Insider Transactions
Merdad Parsey Mailing Address
Above is the net worth, insider trading, and ownership report for Merdad Parsey. You might contact Merdad Parsey via mailing address: 333 Lakeside Drive, Foster City Ca 94404.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
